- Home
- SXTC vs DHF Comparison
SXTC vs DHF Comparison
Compare SXTC & DHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTC
- DHF
- Stock Information
- Founded
- SXTC 2005
- DHF 1998
- Country
- SXTC China
- DHF United States
- Employees
- SXTC N/A
- DHF N/A
- Industry
- SXTC Biotechnology: Pharmaceutical Preparations
- DHF Finance Companies
- Sector
- SXTC Health Care
- DHF Finance
- Exchange
- SXTC Nasdaq
- DHF Nasdaq
- Market Cap
- SXTC 184.5M
- DHF 185.7M
- IPO Year
- SXTC 2019
- DHF N/A
- Fundamental
- Price
- SXTC $1.36
- DHF $2.57
- Analyst Decision
- SXTC
- DHF
- Analyst Count
- SXTC 0
- DHF 0
- Target Price
- SXTC N/A
- DHF N/A
- AVG Volume (30 Days)
- SXTC 25.6K
- DHF 451.1K
- Earning Date
- SXTC 08-19-2019
- DHF 01-01-0001
- Dividend Yield
- SXTC N/A
- DHF 7.65%
- EPS Growth
- SXTC N/A
- DHF N/A
- EPS
- SXTC N/A
- DHF N/A
- Revenue
- SXTC $1,740,907.00
- DHF N/A
- Revenue This Year
- SXTC N/A
- DHF N/A
- Revenue Next Year
- SXTC N/A
- DHF N/A
- P/E Ratio
- SXTC N/A
- DHF N/A
- Revenue Growth
- SXTC N/A
- DHF N/A
- 52 Week Low
- SXTC $0.95
- DHF $2.06
- 52 Week High
- SXTC $7.84
- DHF $2.39
- Technical
- Relative Strength Index (RSI)
- SXTC 40.70
- DHF 47.59
- Support Level
- SXTC $1.20
- DHF $2.56
- Resistance Level
- SXTC $1.43
- DHF $2.58
- Average True Range (ATR)
- SXTC 0.08
- DHF 0.02
- MACD
- SXTC -0.00
- DHF 0.00
- Stochastic Oscillator
- SXTC 53.33
- DHF 66.67
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
About DHF BNY Mellon High Yield Strategies Fund
BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. The fund invests predominantly in fixed-income securities of below-investment-grade credit quality.